Biotech Sector Search Surge

This is a news story, published by Yahoo Finance, that relates primarily to Krystal Biotech news.

Krystal Biotech news

For more Krystal Biotech news, you can click here:

more Krystal Biotech news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Galmed Pharmaceuticals

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest biotech stocks news, biopharmaceutical companies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

biotech sector

TipRanks

•

Health

Biotech Alert: Searches spiking for these stocks today

Summary

Nutrition label

87% Informative

Galmed Pharmaceuticals ( GLMD ), 353% surge in interest - Protagenic Therapeutics (PTIX), 345% .

Krystal Biotech ( KRYS ), 238% surge.

CorMedix (CRMD) and Bio-Techne Corporatiton (TECH) also seeing a substantial increase in interest.

Palatin Technologies announced new preclinical data on its melanocortin agonists PL9654 and PL9655 at the 2025 Association for Research in Vision and Ophthalmology Annual Meeting.

Hepion Pharmaceuticals announced it has entered into a binding letter of intent, LOI , with New Day Diagnostics LLC to in-license diagnostic tests for celiac disease, respiratory multiplex, helicobacter pylori and hepatocellular carcinoma.

Galmed Pharmaceuticals announced that Aramchol enhances the liver / colorectal cancer-approved therapeutic Regorafenib effects in liver and colon cancers.

Rigel Pharmaceuticals reported upbeat Q1 results and reiterated its FY25 revenue outlook.

Krystal Biotech reported mixed Q1 .

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive